Potential Benefit of Low-Dose Candesartan in Trastuzumab-Induced Cardiotoxic Effects.
| Autor: | Yun S; Department of Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida., Khoubyari R; Department of Cardiology, University of Arizona, Tucson., Abraham I; Arizona Cancer Center, University of Arizona, Tucson4Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JAMA oncology [JAMA Oncol] 2017 Feb 01; Vol. 3 (2), pp. 279. |
| DOI: | 10.1001/jamaoncol.2016.3637 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|